Flavored cigarillo study seeks young smokers to test policy scenarios
NCT ID NCT07162935
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study recruits 300 young adults aged 18-24 who smoke cigarillos to understand how different flavors influence their smoking behavior and perceptions. Researchers will measure puff counts and self-reported rewards from smoking, and simulate how changing flavor availability might affect quitting or switching. The goal is to inform future tobacco policies, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
May 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 24 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Ages 18 to 24 2. Report past 30-day use of a cigarillo 3. Ability to read English at least an 8th grade level 4. No immediate plans to quit using tobacco 5. At least 1 prior experience with a flavored tobacco product 6. U.S. Citizen or permanent resident of the United States. Exclusion Criteria: 1. Current use of smoking cessation pharmacotherapy or nicotine replacement therapy; 2. Pregnant, planning to become pregnant, or currently breastfeeding; 3. Past or current clinically significant heart disease or hypertension, or other smoking-related disease that could preclude successful study completion; 4. Inability to abstain from nicotine/tobacco products for at least 12 hours 5. Unwillingness to use the research cigarillos in the lab
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cigar smoking are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Oklahoma Health Campus
RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
West Virginia University
NOT_YET_RECRUITINGMorgantown, West Virginia, 26506, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single talk session help cancer patients quit smoking?
- One extra therapy session may keep cancer patients off cigarettes
- Practice quitting: a new way to help smokers who Aren't ready to stop?
- A new weapon against secondhand smoke: home visits that inspire change
- Text messages and clinic prompts may boost smoking cessation
- Can a short tobacco break curb cannabis cravings?